Skip to main content
Clinical Trials/NCT02399761
NCT02399761CompletedNot Applicable

Newborn Screening for Aromatic L-amino Acid Decarboxylase Deficiency

National Taiwan University Hospital1 site in 1 country154,795 target enrollmentStarted: August 2012Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
154,795
Locations
1
Primary Endpoint
Number of newborns with AADC deficiency

Study Overview

Brief Summary

Parents of newborns will be invited to test if their newborns are affected with Aromatic L-amino Acid Decarboxylase (AADC) deficiency.

Detailed Description

Parents of newborns will be invited to test if their newborns are affected with Aromatic L-amino Acid Decarboxylase (AADC) deficiency. The routine newborn screening dried blood spots sample will be used to test if 3-O-methyldopa (3-OMD) concentration elevates. If positive of screening test, further confirmation tests including physical examination and for mutation. Genetic counseling and treatment option will be provided, too.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Ages
— to 3 Months (Child)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Babies born in Taiwan receive regular new born screening suggested by Ministry of Heath and Welfare.
  • Parents or Legal Guardian sign in the informed consent form.

Exclusion Criteria

  • Parents or Legal Guardian do not agree to sign in the informed consent form.

Outcomes

Primary Outcomes

Number of newborns with AADC deficiency

Time Frame: 3 years

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials